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Abstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA) in animals is a rare finding in Sweden. In horses,
MRSA was first detected in a screening survey in 2007. In 2008, six clinical cases occurred in an equine hospital,
indicating an outbreak.
Method: All MRSA isolates detected, 11 spa-type t011 and one t064 (n = 12), in infected horses (n = 10) and
screening of horses (n = 2) in Sweden from December 2007 to March 2010 were retrospectively analysed with
pulsed-field gel electrophoresis (PFGE) using Cfr9I and ApaI restriction enzymes, to study relationship between the
isolates. Medical records of infected horses and outbreak investigation notes were scrutinised to monitor the
clinical outcome and other aspects of the outbreak.
Results: Eight of the 10 infected horses were linked to one equine hospital and two to another hospital in the same
region. The six horses infected with MRSA in 2008 underwent surgery during the period 22 May-7 July in one of the
hospitals. Four more infections linked to the two hospitals were notified between 2009 and March 2010.
Nine of the 11 spa-type t011 isolates had identical Cfr9I and ApaI PFGE pattern. All six infected horses from 2008
presented with this MRSA. Two t011 isolates differed in one and two bands, respectively, in PFGE.
Nine horses suffered from surgical site infections (SSI). No antimicrobials were used following the MRSA diagnosis
and the infections cleared. The time from surgery to MRSA diagnosis differed greatly between the horses (range
15-52 days).
Conclusions: Association in time and space of six horses infected with an identical MRSA strain of spa-type t011
confirmed an outbreak. Two isolates found in 2009 and 2010 in the outbreak hospital were closely related to the
outbreak strain, indicating one circulating strain. Both spa-type t011 and t064 have been reported in horses in
Europe prior to these findings. The observation that the infections cleared although antimicrobials were not used is
encouraging for future prudent use of antimicrobials. The time from surgery to bacteriological diagnosis was not
acceptable in most cases, as contagious spread was a risk. Sampling when symptoms of infection are noticed and
accurate analysis are thus important.
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Background
Staphylococcus (S.) aureus is a potentially pathogenic
bacterium causing pyogenic infections in both man and
animals. Nosocomial and community-acquired infections
with therapeutic limitations due to methicillin-resistant
S. aureus (MRSA) have become a worldwide problem in
humans [1-5]. However, according to the European
Antimicrobial Resistance Surveillance Network annual
report for 2010, a significant decrease in human MRSA
rates has occurred in seven European countries in
recent years, which might be the result of successful
preventive measures [6].
An increasing number of different animal species
colonised or infected with MRSA has also been reported
during recent decades [7-15]. The first report of MRSA
in horses was in brood mares with endometritis in
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Japan [8,9], but surgical site infections (SSI) and trau-
matic wound infections are more frequently reported
[10,12,14,15]. MRSA associated with livestock, of multi
locus sequence type (MLST) ST398, has emerged in
Europe [15-19]. People with professions involving con-
tact with animals carrying MRSA ST398 are reported to
be colonised with this type to a higher extent than the
average population [2,15,20-23]. Within the cluster of
ST398 one spa-type, t011, is predominant in pigs in
Europe and has also been found e.g. in rats on pig
farms and in cattle [19,24-27]. Spa-type t011 has also
been detected in horses and in equine hospital environ-
ments [15,17,18,28,29]. Human infections with this spa-
type have been reported in Europe [30-32]. MRSA of
spa-type t064, belonging to ST8, has also been described
in horses in Europe, although not as frequently as spa-
type t011 [12,15].
Pulsed-field gel electrophoresis (PFGE) has long been
the ‘gold standard’ for fingerprinting MRSA using SmaI
endonuclease, but ST398 is not typeable by the standar-
dised method [33]. Other enzymes, such as Cfr91, ApaI
and SacII, have proven useful for cutting DNA in ST398
strains [24,34-37].
MRSA and other methicillin-resistant, coagulase-positive
staphylococci detected in animals are notifiable since 1 Jan-
uary 2008, according to Swedish legislation (SJVFS
2007:90). MRSA is rare in animals in Sweden according to:
i) official notification data from the Swedish Board of Agri-
culture (SJV); ii) ongoing annual monitoring of antimicro-
bial-resistant bacteria since 2000 in the Swedish Veterinary
Antimicrobial Resistance Monitoring (SVARM) pro-
gramme; and iii) targeted screening surveys of pigs and
horses within the country [38-40]. However, in 2010 (some
months after this study was completed) for the first time a
Swedish pig herd, one of 191 tested in a national screening
programme, was confirmed as MRSA-positive. The isolate
belonged to ST398, spa-type t011 [39]. MRSA has so far
not been detected in cattle in Sweden [39]. The first docu-
mented MRSA isolate of equine origin in Sweden was from
a screening survey in 2007, when one of 300 healthy horses
presented with ST398, spa-type t011, in a nasal sample [38].
The aim of this study was to employ PFGE to further
analyse all available MRSA isolates from horses in Sweden,
obtained between 2007 and 2010, in order to establish
whether a nosocomial outbreak had occurred and whether
sporadic cases could be connected to this suspected out-
break. An additional aim was to describe the clinical condi-
tions of the suspected outbreak and the outcome for the
horses.
Methods
Design of the study
Retrospective analyses were used to investigate the
genetic relatedness between 12 MRSA isolates detected
between December 2007 and March 2010 in horses in
Sweden, in order to establish whether a nosocomial out-
break had occurred. The outcome for the horses and
other factors of importance were studied by gathering
data from the medical records of infected horses, hospi-
tal notes on surgeries and outbreak investigation
documents.
Isolates
The 12 isolates analysed with PFGE were provided by the
Department of Animal Health and Antimicrobial Strate-
gies at the Swedish National Veterinary Institute (SVA),
which collects isolates of antimicrobial-resistant bacteria
and carries out typing and antimicrobial susceptibility
testing. The isolates represented all MRSA detected in
horses in Sweden in the study period and originated from
clinical sampling of wound infections (n = 10) using
swabs for routine bacteriological sampling or from nasal
screening (n = 2), as listed below and in Table 1.
- Eight isolates were linked to one equine hospital
(Hospital 1), six infected during the summer of 2008
(Horse I, II, III, IV, V and VI) and two sporadic
infections, in 2009 (Horse VIII) and 2010 (Horse IX).
- Two isolates were linked to another hospital in the
same region (Hospital 2), and originated from two
sporadically infected horses, in 2009 (Horse VII) and
2010 (Horse IX).
- Two isolates came from non-infected horses with
positive nasal cultures; one in an anonymous screen-
ing survey in 2007, where one of 300 horses tested
positive [38]; and one from screening of horses that
had been in contact with the infected horses in
2008, where one of 14 horses tested positive.
Culture, susceptibility testing, confirmation of methicillin
resistance and genotyping of the isolates prior to PFGE
The isolates had been analysed at SVA and the Swedish
Institute for Communicable Disease Control (SMI) as
described below before being submitted to this retro-
spective study.
One sample was cultured in an equine hospital’s own
laboratory and the isolate was sent to SVA for MRSA
confirmation and further typing (Table 1). For this iso-
late, the culture method is not known. The remaining
samples were cultured at SVA. Clinical swabs were routi-
nely streaked onto a 5% bovine blood and Bromcresole
Purple Lactose agar plate (both SVA), incubated for 24 to
48 hours at 37°C and checked after 24 and 48 hours for
bacterial growth. When MRSA was suspected by the
sampling clinician, the swab was also streaked onto Brilli-
ance MRSA agar (Oxoid, Basingstoke, UK) and plates
were incubated at 37°C for 24 to 48 h.
The two nasal swabs from screening (Table 1) were
selectively cultivated for MRSA according to Busscher
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et al. [41], with the exception that cefoxitin (1 mg/L)
was used instead of ceftizoxime. Suspected colonies
from the cultivation having typical morphology, such as
haemolysin production on blood agar or blue colonies
on Brilliance MRSA agar, were recultivated and further
phenotyped with biochemical testing (Gram staining,
catalase, coagulase and maltose fermentation). Bio-
chemically verified S. aureus was further tested as
described below. The isolate cultured in the hospital
laboratory was also tested in this way.
In addition to demonstrating resistance to betalactams,
all isolates provided had proved resistant to ciprofloxacin,
gentamicin, kanamycin, tetracycline and trimethoprim and
susceptible to erythromycin, clindamycin and fusidic acid
in previous antimicrobial susceptibility testing of the iso-
lates. This was performed by broth microdilution accord-
ing to standards of the Clinical and Laboratory Standards
Institute guidelines, document M100-S17 [42], using
microdilution panels (VetMIC™, SVA, Uppsala, Sweden).
S. aureus CCUG 15915 was used as quality control. Resis-
tance was defined using epidemiological cut-off values
according to the European Committee on Antimicrobial
Susceptibility Testing [43].
All isolates were confirmed as MRSA by polymerase
chain reaction (PCR) analyses for the mecA gene and the
S. aureus species-specific nuc gene according to Smyth et
al. [44]. Eleven of the 12 isolates were of spa-type t011
(tandem repeats 8-16-2-25-34-22-25) and one of spa-type
t064 (tandem repeats 11-19-12-05-17-34-24-34-22-25).
Spa-typing was performed according to Harmsen et al.
[45] by SMI or SVA. Two spa-type t011 isolates analysed
with MLST according to Enright et al. [46] were identified
as ST398 and the t064 as ST8. MLST of these isolates was
carried out by SMI to confirm expected sequence type
identity, as the spa-types were known.
Horses
Data on the date and type of surgery, antimicrobial treat-
ment, surgical hospital, length of time from the date of
surgery to MRSA detection, progress and clinical out-
come were collected from medical records on the horses.
Post-surgery notes and outbreak investigation notes from
Hospital 1 provided information relating to the outbreak.
Pulsed-field gel elctrophoresis
Macro-restriction analysis of the isolates was performed
at SVA. As the restriction enzyme typically used for
PFGE of MRSA, SmaI, is blocked by methylation of spe-
cific recognition sites in ST398 strains [37], the enzymes
Cfr9I, a neoschizomer of SmaI, and ApaI were chosen
instead [24,34-36] and used according to the HAR-
MONY protocol [33]. Chromosomal DNA of S. aureus
NCTC 8325 was used as the reference size marker for
normalisation of PFGE gels. Banding patterns were com-
pared visually and the level of similarity between pat-
terns used for defining pulsotypes was a minimum of
one band difference, according to guidelines devised by
Tenover et al. [47].
Table 1 Methicillin-resistant Staphylococcus aureus in horses in Sweden, December 2007 to March 2010.
Year Date of
surgery
Type of surgery Inf1) Pulsotype2) Hospital (MRSA
case)
Outcome/comments
2007 NA 3) NA, nasal screening NA A NA First known MRSA case in horses in Sweden [38]
2008 May 22 Tenoscopy SSI A 1 (Horse I) Euthanized 2 June
May 26 Ovariectomy SSI A 1 (II) Healed, sampled twice, neg on 1st occasion, pos on
2nd
Jun 2 Ovariectomy SSI A 1 (III) Healed
Jul 2 Ovariectomy SSI A 1 (IV) Healed
Jul 4 Umbilical hernia SSI A 1 (V) Healed, found in phone tracing
Jul 7 Colic SSI A 1 (VI) Healed, sampled twice, neg on 1st occasion, pos on
2nd
NA NA, nasal screening NA A NA NA, contact tracing
2009 Aug 25 Extensor tendon
rupture
SSI A2 2 (VII) Healed
Aug 4) NA, inf. pressure
wound
TW A 1 (VIII) Healed
2010 Feb 4 Tenectomy SSI A1 1 (IX) Healed
Feb 27 Colic SSI B 2 (X) Healed, culture by hospital lab, ST8, spa-type t064
Isolates were of ST 398, spa-type t011, unless otherwise stated.
1) Type of infection; surgical site infection (SSI), traumatic wound (TW).
2) PFGE pulsotype, ApaI and Cfr91 restriction enzyme, see Figure 1 for details.
3) NA = not applicable or not known.
4) Foal, admission in June 2009 for neonatal care. In August a second visit, surgery due to a broken injection needle in a muscle which healed. Third visit, a
pressure sore in a front leg due to bandage in which MRSA was detected in Sept 2009.
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Results
Horses and outbreak data
Where the horses lived was known for 11 of the 12 horses
and their home stables were located in a region approxi-
mately between 20 and 200 km from the Swedish capital,
Stockholm (Figure 1). The screening in 2007 was anon-
ymous and thus no data were available for this horse. Date
and type of surgery, type of infection, surgical hospital and
outcome for the infected horses are shown in Table 1. No
medical records were available for the two non-infected
horses that tested positive in the screening studies.
The first MRSA case (Table 1 Horse I) in the outbreak
related to Hospital 1 underwent surgery on 22 May and
was diagnosed as infected in June 2008. During the sum-
mer of 2008 five more horses became infected (Table 1
Horses II, III, IV, V and VI). In tracing for a possible
source, it was noted that the three horses that underwent
surgery between 22 May and 2 June (Horses I, II and III)
had indirect contacts within the hospital. Horse I was
readmitted to the hospital four days after surgery because
of swelling in the surgery area and the operated tendon
sheath was flushed both before and after horse II under-
went surgery in the same theatre. During the last flushing
of Horse I, on 2 June, a bacteriological sampling was per-
formed and the horse was then euthanized due to guarded
prognosis. On 2 June Horse III also underwent surgery
(laparoscopy) in another surgical theatre, but with instru-
ments used previously for the tenoscopy on Horse I.
Instruments had been routinely cleaned and disinfected or
autoclaved between patients. Thus in summary, Horses I
and II had indirect contact through the operating theatre
and Horses I and III through surgical instruments. Horses
I, II and III were all born in Sweden and had no history of
being abroad, but contacts with other horses within Swe-
den and their origin and cross-connections could not be
tracked down when searching for possible transmission
outside the hospital. The next cluster of three infected
horses (Table 1 Horses IV, V and VI) had surgery within a
five-day period, 2-7 July, about a month later.
After the outbreak in summer 2008, four more horses
infected with MRSA were notified in Sweden by March
2010; two in Hospital 1 and two linked to Hospital 2
(Table 1).
According to medical records, infections were superficial
in eight of the 10 infected horses. The infection in the ten-
don sheath of Horse I was recorded as severe, but as this
horse was euthanized the outcome of the infection could
not be evaluated. The wound infection of the horse with
the ruptured extensor tendon (Horse VII) had visible bone
but intact periosteum and was also judged as rather severe.
Medical treatment before MRSA diagnosis was not
recorded for all horses, but when MRSA was diagnosed no
antimicrobials were administered to the nine infected
horses still alive (Horse I already euthanized). According
to the medical records, the infections cleared and wounds
healed in all the horses evaluated.
The entire time span from the day of surgery to labora-
tory confirmation of MRSA differed widely between
the horses, ranging from 15 to 52 days (median 26 days).
Five of the 10 infected horses were sampled in the hospi-
tal, one still hospitalised after surgery (Horse VI) and four
when readmitted because of infected non-healing wounds
(Horses I, VIII, IX and X). The remaining five were
sampled at home and of those was one traced by tele-
phone (Horse V) as described below (Table 1). Of the six
outbreak horses two were sampled twice as their infections
did not clear and MRSA was not detected on the first but
on the second sampling occasion (Horses II and VI). The
remaining infected horses tested positive for MRSA on the
first sampling occasion. The history of antimicrobial treat-
ment before sampling could not be determined for all
horses, but at least one horse (IX) was treated with penicil-
lin for a week, without effect, before sampling. One of the
horses (Horse V) in the outbreak was found in a telephone
tracing of owners of horses that underwent surgery within
the outbreak period, 22 May-7 July, when searching for
potentially infected horses connected to Hospital 1. Of 45
listed owners 37 were reached, four reported clinical signs
of infection in their horses, three horses were sampled and
one tested positive. The time from bacteriological sam-
pling of horses with infections to laboratory confirmation
of MRSA ranged between three and 10 days (median 7
days). The time taken for analysis was influenced by vari-
able quality of samples, laboratory closure on weekends
and parcel delivery time.
There were no known direct connections between
Hospitals 1 and 2.
Genotyping
The PFGE pulsotypes are shown in Figure 2 and Table
1. Identical Cfr9I and ApaI band patterns were seen for
nine of the 12 isolates, here named pulsotype A.
According to the definition by Tenover et al. [47], those
isolates were genetically indistinguishable and repre-
sented the same strain. One isolate, named pulsotype
A1, lacked one band in the ApaI gel compared with pul-
sotype A, but was identical to pulsotype A in the Cfr9I
gel. One isolate, named pulsotype A2, linked to Hospital
2 and found in 2009, about a year after the outbreak,
showed A1 pattern in ApaI gel but also had an extra
band in the Cfr9I gel. Pulsotypes A1 and A2 can be con-
sidered very closely related to the pulsotype A according
to Tenover et al. [47], and any differences should be
considered as normal genetic change over time. The
third divergent isolate was of spa-type t064, showing a
totally different gel pattern with both enzymes.
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Discussion
This study confirmed the first nosocomial outbreak of
MRSA in a Swedish equine hospital. This was also the
first MRSA infections notified in horses in Sweden,
although one nasal carrier of spa-type t011 had been
found in a screening survey of horses about six month
earlier, in December 2007 [38]. As the screening was
anonymous, it could not be determined whether there
Figure 1 Red dot indicate approximate location of MRSA-infected horses in Sweden, June 2008 to March 2010.
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were connections between that finding and the subse-
quent outbreak. The outbreak strain belonged to the
MRSA variant ST398, spa-type t011 [38,39]. This variant
has been associated with livestock in Europe [12,19] and
with horses [15,17,18,28,29], but had only been found in
horses and a few humans [48] in Sweden.
The ST398, spa-type t011, isolates from Swedish horses
were indistinguishable or very closely related according
to PFGE, which corroborated the close relationship
between them. The use of two restriction enzymes
offered good discrimination between the isolates and
revealed minor genetic change over time, from pulsotype
A into pulsotype A1 in Hospital 1 (2010, Horse IX) and
pulsotype A2 in Hospital 2 (2009, Horse VII). The pulso-
types A1 and A2 were isolated more than a year after
pulsotype A and genetic events in a strain leading to
changes in restriction site are not surprising, according
to Tenover et al. [47] and indicated one circulating strain
in the region.
It was not possible to find a plausible source of the out-
break since the index case could not be defined, as the
first three horses infected had indirect cross-contacts
within the hospital. Moreover, horses were not screened
for MRSA on arrival at the equine hospital, probably
because MRSA had not yet been identified as a risk in
Sweden. Horses regularly travel to competitions and for
breeding and change owners over regional and national
borders. The MRSA in this study could well have origi-
nated from connections to livestock or horses in countries
with a higher MRSA prevalence than Sweden. As MRSA
Figure 2 PFGE pattern of representative MRSA isolates, spa-type t011 and t064. Restrictions enzyme ApaI and Cfr9I. ApaI: Lane 1 -
demonstrate the outbreak strain named pulsotype A. Lane 2 - pulsotype A1 and A2 isolates lacking one band. Cfr9I: Lane 5 - pulsotype A and
lanes 7 + 8 - pulsotype A1, identical in Cfr9I gel. Lane 6 - pulsotype A2, one extra band. Lanes 11 and 12 show difference between spa-type
t011 (pulsotype A) and spa-type t064 (pulsotype B). C = control: S. aureus NCTC 8325 L = lambda ladder: Size range of 50-1,000 kb (PFG Marker,
New England Biolabs Inc.) http://www.neb.com/nebecomm/products/productN0340.asp.
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had not been found in livestock in Sweden at that time, it
seemed less likely that Swedish livestock would be the
source [39,40]. The infection might even have derived
from human carriers, such as people handling the horses,
as professionals working with animals that carry MRSA
ST398 have been reported to be colonised with this type
[2,15,20-23]. The infected horse found during telephone
tracing of the owners of horses that had undergone sur-
gery during the outbreak period in Hospital 1 might have
been overlooked otherwise, as the owner expressed no
worry about secretions from the wound. This indicates a
need for post-operative monitoring of horses in order to
track down surgical complications, but also to communi-
cate general information about signs of resistant bacteria
to veterinary staff, horse owners and other people working
with horses. The findings also point out a possible bias in
estimated numbers of hospital-acquired infections based
upon infections diagnosed solely within the hospital or
clinic.
A different spa-type, t064, was introduced to Sweden
almost two years after the outbreak in Hospital 2 (Table 1
Horse X). This spa-type has been reported in horses in
other countries [12,15,49,50]. In Hospital 2 another horse
(Table 1 Horse VIII) suffered from MRSA pulsotype A2,
which was a minor genetic change of pulsotype A from
the Hospital 1 outbreak. The two cases in Hospital 2
occurred approximately six months apart and was appar-
ently not an outbreak, but the incident initiated a need for
revision of the infection control procedures within the
hospital. Such revision and improvement had already
started at Hospital 1.
The majority of the MRSA infections identified in this
study were SSI, confirming previous reports, although
other infections do occur [8-10,12,14,15,17,28,51].
The zoonotic potential of MRSA means that infected
and carrier horses could pose a risk to hospital staff and
horse owners. Seven human cases of spa-type t011 were
notified between 2006 and 2010 in Sweden [48], and the
findings of spa-type t011 in people could be the result of
animal to human transmission. It would be interesting to
compare Swedish spa-type t011 MRSA isolates from peo-
ple and horses by PFGE. In a Finnish study, isolates of
spa-type t011 from people without horse contact showed
a different PFGE pattern than t011 isolates from a veteri-
narian and horses in contact during a MRSA outbreak in
an equine hospital [52].
The isolates tested here were resistant to all antimicro-
bials approved for equine use in Sweden and the only
treatment options were drugs with a risk of inducing coli-
tis in horses, e.g. erythromycin [53] and one for local use,
fusidic acid. Spontaneous clearing of the infections with-
out antimicrobial treatment was an encouraging observa-
tion, as there was no approved drug available in the
studied cases and antimicrobial resistance is expanding
and antimicrobials are considered a limited resource
[54,55]. Wound care without antimicrobial treatment is a
topic that needs to be further explored within veterinary
practices, as well as in research.
The great variation in time from surgery to MRSA
detection (15-52 days) was not acceptable, as delayed
detection might influence the numbers of horses infected
in an outbreak, as well as posing a hazard to staff. Some of
the delay could be explained by negative cultures on the
first sampling occasion and at least one unaware owner,
the telephoned-traced case. Other reasons for delay were
empirical antimicrobial treatment before sampling (Horse
X) and delayed sampling (Horse I). Lack of awareness or
neglect by veterinarians and others are hypothetical rea-
sons for delays. The findings showed that infections
should be taken seriously and would benefit from qualified
sampling before antimicrobial use, although negative cul-
ture is a risk, as demonstrated in two of the cases in this
study. The time between bacteriological sampling and
laboratory confirmation of MRSA was also long in some
cases. Culture for MRSA is a balance between speed of
result, sensitivity, specificity and cost. A suitable sampling
technique is vital for faster culture. Pre-washing of the top
layer of an infected wound with sterile saline, water or
likewise to remove decomposition flora might help to
decrease the delay that arises from analysing mixed flora,
especially if MRSA selective agar plates are not used and
the growth of decomposition flora requires recultivation.
However, there could also be delays because of lack of
awareness or dismissal of MRSA by laboratories, since
MRSA had not been detected previously in Sweden. Accu-
rate diagnosis is important for all concerned; patient,
owner, veterinary staff, etc. Verification of MRSA isolates
by PCR is essential, since a false diagnosis of MRSA is as
devastating as a true positive. Faster methods would be
preferable to obtain a quick yes or no answer, but culture
will still be required to get isolates for antimicrobial sus-
ceptibility testing and genetic and epidemiology studies.
Real-time PCR as used for humans has been evaluated for
detecting MRSA in horses, but proved unsatisfactory [56].
The MRSA outbreak raised an alarm for equine veteri-
narians and hospital staff in Sweden and increased their
awareness about the need for improved infection control
for their own safety and that of the horses. In addition,
during the outbreak, the topic was reported and dis-
cussed frequently and thoroughly in the media, making
the general public aware of the presence of MRSA bac-
teria in the equine population.
Conclusions
MRSA was shown to be present in the Swedish equine
population, although it appeared only regionally. The
restriction enzymes Cfr9I and ApaI worked well for
MRSA ST398 and demonstrated close genetic relatedness
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between most isolates from the horses tested, represent-
ing one strain. This and the correlation in time and space
between the cases verified the occurrence of an outbreak.
Later sporadic infections with the same strain indicated
one circulating strain, but the primary source of the out-
break was never identified.
The outbreak highlights the importance of implement-
ing preventive measures, such as sampling of infections,
improved infection control with strict hygiene routines
and antimicrobial strategies, to limit the spread of
MRSA in animal hospitals. An encouraging observation
was that infections cleared although no antimicrobial
treatment was given. Wound care without antimicrobials
would benefit from further research, as antimicrobials
have become a limited resource within both human and
veterinary medicine.
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